Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • FDA alerts consumers...

    FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr

    Written by supriya kashyap kashyap Published On 2017-04-02T11:49:56+05:30  |  Updated On 2 April 2017 11:49 AM IST

    The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions. This recall is due to the potential that these devices may contain a defective part that may result in the devices’ failure to activate. The recalled product was manufactured by Meridian Medical Technologies and distributed by Mylan Specialty.


    While the number of reported failures is small, EpiPen products that potentially contain a defective part are being recalled because of the potential for life-threatening risk if a severe allergic reaction goes untreated. Consumers should keep and use their current EpiPens if needed until they get a replacement. Consumers should contact Mylan at 800-796-9526 or customer.service@mylan.com with any questions.


    As stated on the product label, consumers should always seek emergency medical help right away after using their EpiPens, particularly if the device did not activate.


    At this time, the 13 lots identified distributed between Dec. 17, 2015, and July 1, 2016 are the only EpiPen lots impacted by the U.S. recall. Consumers who have EpiPens from lots that are not included in this recall, do not need to replace their EpiPen prior to its expiration date.


























































































    Product/DosageNDC NumberLot NumberExpiration Date
    EpiPen Jr Auto-Injector, 0.15 mg49502-501-025GN767April 2017
    EpiPen Jr Auto-Injector, 0.15 mg49502-501-025GN773April 2017
    EpiPen Auto-Injector, 0.3 mg49502-500-025GM631April 2017
    EpiPen Auto-Injector, 0.3 mg49502-500-025GM640April 2017
    EpiPen Jr Auto-Injector, 0.15 mg49502-501-026GN215September 2017
    EpiPen Auto-Injector, 0.3 mg49502-500-026GM082September 2017
    EpiPen Auto-Injector, 0.3 mg49502-500-026GM072September 2017
    EpiPen Auto-Injector, 0.3 mg49502-500-026GM081September 2017
    EpiPen Auto-Injector, 0.3 mg49502-500-026GM088October 2017
    EpiPen Auto-Injector, 0.3 mg49502-500-026GM199October 2017
    EpiPen Auto-Injector, 0.3 mg49502-500-026GM091October 2017
    EpiPen Auto-Injector, 0.3 mg49502-500-026GM198October 2017
    EpiPen Auto-Injector, 0.3 mg49502-500-026GM087October 2017

    The FDA asks health care professionals and consumers to report any adverse reactions or device malfunctions to the FDA’s MedWatch program, by:




    • Completing and submitting the report online at www.fda.gov/medwatch/report.htm, or

    • Downloading and completing the form, then submitting it via fax at 800-FDA-0178.


    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

    epinephrine injectionEpiPenEpiPen JrMeridian Medical TechnologiesMylanUS Department of Health and Human ServicesUS Food and Drug AdministrationUSFDAvoluntary recall
    Source : FDA

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok